Pharmacy Medical News about Parkinson Disease

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

An open-label conversion study of pramipexole to ropinirole prolonged release in Parkinson's disease
Movement Disorders, 09/22/09

Lyons KE et al. – These subjects were taking a significantly greater dose of pramipexole, the majority greater than 4 mg/day, and tended to have longer disease durations. A conversion ratio of 1 mg of pramipexole to 4 mg of ropinirole PR resulted in the fewest discontinuations of ropinirole PR, the fewest dose adjustments and the largest percentage of subjects that preferred ropinirole PR.

<< Previous
Successful Use of Dexmedetomidine for Sedation in a 24-Week...

Next >>
Pharmacokinetic Properties of Sulfadoxine-Pyrimethamine in...

Widely Used Cholesterol-lowering Drug May Prevent Progression Of Parkinsons Disease
ScienceDaily, 11/10/09 Relevance Score: 70%

Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia
Brain, 10/30/09 Relevance Score: 70%

Effects of optimism/pessimism and locus of control on disability and quality of life in Parkinson's disease
Parkinsonism & Related Disorders, 10/29/09 Relevance Score: 69%

Sleep disturbances in Malaysian patients with Parkinson's disease using polysomnography and PDSS
Parkinsonism & Related Disorders, 10/29/09 Relevance Score: 69%

Condition Raises Parkinsons Risk 5-Fold
Ivanhoe, 10/27/09 Relevance Score: 69%